Candidate Biomarkers for Targeting in Type 1 Diabetes; A Bioinformatic Analysis of Pancreatic Cell Surface Antigens.

Autor: Dabiri, Hamed^1,2, Habibi-Anbouhi, Mahdi³ habibi_m@pasteur.ac.ir, Ziaei, Vahab³, Moghadasi, Zahra³, Sadeghizadeh, Majid¹ sadeghma@modares.ac.ir, Hajizadeh-Saffar, Ensiyeh^4,5 en.hajizadeh@royan-rc.ac.ir

Publikováno v: Cell Journal (Yakhteh). Jan2024, Vol. 26 Issue 1, p51-61. 11p.

Candidate Biomarkers for Targeting in Type 1 Diabetes; A Bioinformatic Analysis of Pancreatic Cell Surface Antigens

Autor: Hamed Dabiri, Mahdi Habibi-Anbouhi, Vahab Ziaei, Zahra Moghadasi, Majid Sadeghizadeh, Ensiyeh Hajizadeh-Saffar

Publikováno v: Cell Journal, Vol 26, Iss 1, Pp 51-61 (2024)

Objective: Type 1 diabetes (T1Ds) is an autoimmune disease in which the immune system invades and destroysinsulin-producing cells. Nevertheless, at the time of diagnosis, about 30-40% of pancreatic beta cells are healthy andcapable of producing insul

Externí odkaz: https://doaj.org/article/92b2739b94c34fefa81181a2be361723

Outer membrane protein C is a protective and unique vaccine antigen against Shigella flexneri 3a.

Autor: Jarząb, Anna¹ (AUTHOR) anna.jarzab@hirszfeld.pl, Dąbrowska, Anna² (AUTHOR), Naporowski, Piotr¹ (AUTHOR), Krasna, Karina¹ (AUTHOR), Szmyt, Agnieszka² (AUTHOR), Świat, Michał¹ (AUTHOR), Pawlik, Krzysztof¹ (AUTHOR), Witkowska, Danuta¹ (AUTHOR), Ziomek, Edmund¹ (AUTHOR), Gamian, Andrzej¹ (AUTHOR)

Publikováno v: Scientific Reports. 10/25/2024, Vol. 14 Issue 1, p1-11. 11p.

Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma

Autor: Takahide Nejo, Lin Wang, Kevin K. Leung, Albert Wang, Senthilnath Lakshmanachetty, Marco Gallus, Darwin W. Kwok, Chibo Hong, Lee H. Chen, Diego A. Carrera, Michael Y. Zhang, Nicholas O. Stevers, Gabriella C. Maldonado, Akane Yamamichi, Payal B. Watchmaker, Akul Naik, Anny Shai, Joanna J. Phillips, Susan M. Chang, Arun P. Wiita, James A. Wells, Joseph F. Costello, Aaron A. Diaz, Hideho Okada

Publikováno v: Scientific Reports, Vol 14, Iss 1, Pp 1-17 (2024)

Abstract Despite advancements in cancer immunotherapy, solid tumors remain formidable challenges. In glioma, profound inter- and intra-tumoral heterogeneity of antigen landscape hampers therapeutic development. Therefore, it is critical to consider a

Externí odkaz: https://doaj.org/article/4c9ca26f096d46feb278b4dfc8e66f04

Selection, engineering, and in vivo testing of a human leukocyte antigen–independent T-cell receptor recognizing human mesothelin.

Autor: Hiscox, Martyn J.¹ (AUTHOR) Martyn.Hiscox@adaptimmune.com, Wasmuth, Alexandra¹ (AUTHOR), Williams, Chris L.¹ (AUTHOR), Foot, Jaelle N.¹ (AUTHOR), Wiedermann, Guy E.¹ (AUTHOR), Fadda, Valeria¹ (AUTHOR), Boiani, Sara¹ (AUTHOR), Cornforth, Terri V.¹ (AUTHOR), Wikiert, Karolina A.¹ (AUTHOR), Bruton, Shaun¹ (AUTHOR), Cartwright, Neil¹ (AUTHOR), Anderson, Victoria Elizabeth¹ (AUTHOR), Barnes, Christopher S.¹ (AUTHOR), Vieira, Joao V.¹ (AUTHOR), Birch-Machin, Ian¹ (AUTHOR), Gerry, Andrew B.¹ (AUTHOR), Miller, Karen¹ (AUTHOR), Pumphrey, Nicholas J.¹ (AUTHOR)

Publikováno v: PLoS ONE. 4/4/2024, Vol. 19 Issue 4, p1-21. 21p.